Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Molecular Pharmacology
|
July 12, 2007
Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?
Robert Newton, Neil S Holden
Drug Discovery Today. Disease Mechanisms
|
May 7, 2020
New aspects of p38 mitogen activated protein kinase (MAPK) biology in lung inflammation
Robert Newton, Neil S Holden
Journal of Pharmacological and Toxicological Methods
|
March 30, 2010
Principles and problems of the electrophoretic mobility shift assay
Neil S Holden, Claire E Tacon
European Journal of Applied Physiology
|
August 9, 2020
Inflammatory responses to acute exercise during pulmonary rehabilitation in patients with COPD
Alex R Jenkins, Neil S Holden, Arwel W Jones
COPD
|
May 5, 2020
Clinical Outcomes and Inflammatory Responses of the Frequent Exacerbator in Pulmonary Rehabilitation: A Prospective Cohort Study
Alex R Jenkins, Neil S Holden, Luke P Gibbons, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 4, 2009
Selective transcriptional down-regulation of human rhinovirus-induced production of CXCL10 from airway epithelial cells via the MEK1 pathway
Raza S Zaheer, Rommy Koetzler, Neil S Holden, et al.
The Journal of Biological Chemistry
|
August 4, 2009
Inhibition of NF-kappaB-dependent transcription by MKP-1: transcriptional repression by glucocorticoids occurring via p38 MAPK
Elizabeth M King, Neil S Holden, Wei Gong, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 31, 2011
Inflammatory stimuli inhibit glucocorticoid-dependent transactivation in human pulmonary epithelial cells: rescue by long-acting beta2-adrenoceptor agonists
Christopher F Rider, Elizabeth M King, Neil S Holden, et al.
British Journal of Pharmacology
|
February 22, 2005
Validation of IKK beta as therapeutic target in airway inflammatory disease by adenoviral-mediated delivery of dominant-negative IKK beta to pulmonary epithelial cells
Matthew C Catley, Joanna E Chivers, Neil S Holden, et al.
European Journal of Biochemistry
|
February 7, 2004
ICAM-1 expression is highly NF-kappaB-dependent in A549 cells. No role for ERK and p38 MAPK
Neil S Holden, Matthew C Catley, Lisa M Cambridge, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Molecular Pharmacology
|
July 12, 2007
Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?
Robert Newton, Neil S Holden
Drug Discovery Today. Disease Mechanisms
|
May 7, 2020
New aspects of p38 mitogen activated protein kinase (MAPK) biology in lung inflammation
Robert Newton, Neil S Holden
Journal of Pharmacological and Toxicological Methods
|
March 30, 2010
Principles and problems of the electrophoretic mobility shift assay
Neil S Holden, Claire E Tacon
European Journal of Applied Physiology
|
August 9, 2020
Inflammatory responses to acute exercise during pulmonary rehabilitation in patients with COPD
Alex R Jenkins, Neil S Holden, Arwel W Jones
COPD
|
May 5, 2020
Clinical Outcomes and Inflammatory Responses of the Frequent Exacerbator in Pulmonary Rehabilitation: A Prospective Cohort Study
Alex R Jenkins, Neil S Holden, Luke P Gibbons, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 4, 2009
Selective transcriptional down-regulation of human rhinovirus-induced production of CXCL10 from airway epithelial cells via the MEK1 pathway
Raza S Zaheer, Rommy Koetzler, Neil S Holden, et al.
The Journal of Biological Chemistry
|
August 4, 2009
Inhibition of NF-kappaB-dependent transcription by MKP-1: transcriptional repression by glucocorticoids occurring via p38 MAPK
Elizabeth M King, Neil S Holden, Wei Gong, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 31, 2011
Inflammatory stimuli inhibit glucocorticoid-dependent transactivation in human pulmonary epithelial cells: rescue by long-acting beta2-adrenoceptor agonists
Christopher F Rider, Elizabeth M King, Neil S Holden, et al.
British Journal of Pharmacology
|
February 22, 2005
Validation of IKK beta as therapeutic target in airway inflammatory disease by adenoviral-mediated delivery of dominant-negative IKK beta to pulmonary epithelial cells
Matthew C Catley, Joanna E Chivers, Neil S Holden, et al.
European Journal of Biochemistry
|
February 7, 2004
ICAM-1 expression is highly NF-kappaB-dependent in A549 cells. No role for ERK and p38 MAPK
Neil S Holden, Matthew C Catley, Lisa M Cambridge, et al.
Page
of 3